Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Open-label, Non-comparative Study of Safety and Efficacy of Synagis in Children at High Risk of Severe Respiratory Syncytial Virus Infection in the Russian Federation

NCT01006629 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01006629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01006629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Open-label, Non-comparative Study of Safety and Efficacy of Synagis in Children at High Risk of Severe Respiratory Syncytial Virus Infection in the Russian Federation
Lead sponsor
Abbott
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2009
Completion date
July 31, 2010
Enrollment
100 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, congenital heart disease, premature birth, respiratory syncytial virus infection